In last trading session, Anavex Life Sciences Corporation (NASDAQ:AVXL) saw 0.87 million shares changing hands with its beta currently measuring 0.64. Company’s recent per share price level of $5.15 trading at -$0.41 or -7.37% at ring of the bell on the day assigns it a market valuation of $436.72M. That closing price of AVXL’s stock is at a discount of -102.91% from its 52-week high price of $10.45 and is indicating a premium of 36.89% from its 52-week low price of $3.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.64 million shares which gives us an average trading volume of 1.10 million if we extend that period to 3-months.

For Anavex Life Sciences Corporation (AVXL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.16 in the current quarter.

Anavex Life Sciences Corporation (NASDAQ:AVXL) trade information

Upright in the red during last session for losing -7.37%, in the last five days AVXL remained trading in the red while hitting it’s week-highest on Tuesday, 09/03/24 when the stock touched $5.15 price level, adding 15.02% to its value on the day. Anavex Life Sciences Corporation’s shares saw a change of -44.68% in year-to-date performance and have moved -13.74% in past 5-day. Anavex Life Sciences Corporation (NASDAQ:AVXL) showed a performance of -15.30% in past 30-days. Number of shares sold short was 19.75 million shares which calculate 15.75 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 11 to the stock, which implies a rise of 53.18% to its current value. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 11. It follows that stock’s current price would drop -113.59% in reaching the projected high whereas dropping to the targeted low would mean a loss of -113.59% for stock’s current value.

Anavex Life Sciences Corporation (AVXL) estimates and forecasts

Statistics highlight that Anavex Life Sciences Corporation is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -0.77% of value to its shares in past 6 months, showing an annual growth rate of 8.33% while that of industry is 17.90. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -9.03% during past 5 years.

Anavex Life Sciences Corporation (NASDAQ:AVXL)’s Major holders

Insiders are in possession of 3.05% of company’s total shares while institution are holding 31.83 percent of that, with stock having share float percentage of 32.83%. Investors also watch the number of corporate investors in a company very closely, which is 31.83% institutions for Anavex Life Sciences Corporation that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at AVXL for having 6.39 million shares of worth $26.97 million. And as of 2024-06-30, it was holding 7.7506 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.55 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.5154 of outstanding shares, having a total worth of $19.19 million.